Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.

Jennifer Michelle Trujillo

TitleProfessor
InstitutionUniversity of Colorado Denver - Anschutz Medical Campus
DepartmentSOP-Administration
Phone303/724-2624

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Doyle-Delgado K, Chamberlain JJ, Shubrook JH, Skolnik N, Trujillo J. Pharmacologic Approaches to Glycemic Treatment of Type 2 Diabetes: Synopsis of the 2020 American Diabetes Association's Standards of Medical Care in Diabetes Clinical Guideline. Ann Intern Med. 2020 Nov 17; 173(10):813-821. PMID: 32866414.
      View in: PubMed
    2. Trujillo J. Safety and tolerability of once-weekly GLP-1 receptor agonists in type 2 diabetes. J Clin Pharm Ther. 2020 Sep; 45 Suppl 1:43-60. PMID: 32910487.
      View in: PubMed
    3. Lowe RN, Trujillo JM. Intranasal Glucagon: A New Way to Treat Hypoglycemic Emergencies. Ann Pharmacother. 2020 08; 54(8):780-787. PMID: 32052651.
      View in: PubMed
    4. Anderson SL, Beutel TR, Trujillo JM. Oral semaglutide in type 2 diabetes. J Diabetes Complications. 2020 04; 34(4):107520. PMID: 31952996.
      View in: PubMed
    5. Rudolph M, Gortney JS, Brownfield A, Caldwell D, Castleberry A, Le UM, Medina MS, Sease JM, Trujillo J, Welch AC, Daugherty KK. Student perceptions of the utility of the Pharmacy Curriculum Outcomes Assessment. Curr Pharm Teach Learn. 2020 03; 12(3):255-264. PMID: 32273060.
      View in: PubMed
    6. Nuffer W, Williams B, Trujillo JM. A review of sotagliflozin for use in type 1 diabetes. Ther Adv Endocrinol Metab. 2019; 10:2042018819890527. PMID: 31807264.
      View in: PubMed
    7. Turrin KB, Trujillo JM. Effects of Diabetes Numeracy on Glycemic Control and Diabetes Self-Management Behaviors in Patients on Insulin Pump Therapy. Diabetes Ther. 2019 Aug; 10(4):1337-1346. PMID: 31148053.
      View in: PubMed
    8. Patel D, Triplitt C, Trujillo J. Appropriate Titration of Basal Insulin in Type 2 Diabetes and the Potential Role of the Pharmacist. Adv Ther. 2019 05; 36(5):1031-1051. PMID: 30900198.
      View in: PubMed
    9. Zhou AY, Trujillo JM. Comparison of Usability, Accuracy, Preference, and Satisfaction Among Three Once-Weekly GLP-1 Receptor Agonist Pen Devices. Diabetes Spectr. 2018 Nov; 31(4):359-366. PMID: 30510393.
      View in: PubMed
    10. Trujillo JM, Roberts M, Dex T, Chao J, White J, LaSalle J. Low incidence of gastrointestinal adverse events over time with a fixed-ratio combination of insulin glargine and lixisenatide versus lixisenatide alone. Diabetes Obes Metab. 2018 11; 20(11):2690-2694. PMID: 29923298.
      View in: PubMed
    11. Tuchscherer RM, Thompson AM, Trujillo JM. Semaglutide: The Newest Once-Weekly GLP-1 RA for Type 2 Diabetes. Ann Pharmacother. 2018 12; 52(12):1224-1232. PMID: 29932006.
      View in: PubMed
    12. Pearson SM, Trujillo JM, McDermott MT. 5-alpha-dihydrotestosterone elevations associated with phentermine use. Ther Adv Endocrinol Metab. 2018; 9(8):255-258. PMID: 30181851.
      View in: PubMed
    13. Johnson EL, Frias JP, Trujillo JM. Anticipatory guidance in type 2 diabetes to improve disease management; next steps after basal insulin. Postgrad Med. 2018 May; 130(4):365-374. PMID: 29569978.
      View in: PubMed
    14. Pearson SM, Trujillo JM. Conversion from insulin glargine U-100 to insulin glargine U-300 or insulin degludec and the impact on dosage requirements. Ther Adv Endocrinol Metab. 2018 Apr; 9(4):113-121. PMID: 29619208.
      View in: PubMed
    15. Nuffer W, Guesnier A, Trujillo JM. A review of the new GLP-1 receptor agonist/basal insulin fixed-ratio combination products. Ther Adv Endocrinol Metab. 2018 Mar; 9(3):69-79. PMID: 29492243.
      View in: PubMed
    16. Anderson SL, Trujillo JM, Anderson JE, Tanenberg RJ. Switching basal insulins in type 2 diabetes: practical recommendations for health care providers. Postgrad Med. 2018 Mar; 130(2):229-238. PMID: 29260929.
      View in: PubMed
    17. Trujillo JM, Goldman J. Lixisenatide, a Once-Daily Prandial Glucagon-Like Peptide-1 Receptor Agonist for the Treatment of Adults with Type 2 Diabetes. Pharmacotherapy. 2017 Aug; 37(8):927-943. PMID: 28556176.
      View in: PubMed
    18. Goldman J, Trujillo JM. iGlarLixi: A Fixed-Ratio Combination of Insulin Glargine 100 U/mL and Lixisenatide for the Treatment of Type 2 Diabetes. Ann Pharmacother. 2017 Nov; 51(11):990-999. PMID: 28645216.
      View in: PubMed
    19. Saseen JJ, Linnebur SA, Borgelt LM, Trujillo J, Fish DN, Mueller S. A Pharmacotherapy Capstone Course to Target Student Learning and Programmatic Curricular Assessment. Am J Pharm Educ. 2017 Apr; 81(3):45. PMID: 28496265.
      View in: PubMed
    20. Haines ST, Pittenger AL, Stolte SK, Plaza CM, Gleason BL, Kantorovich A, McCollum M, Trujillo JM, Copeland DA, Lacroix MM, Masuda QN, Mbi P, Medina MS, Miller SM. Core Entrustable Professional Activities for New Pharmacy Graduates. Am J Pharm Educ. 2017 02 25; 81(1):S2. PMID: 28289312.
      View in: PubMed
    21. Trujillo JM, Nuffer WA. Impact of Sodium-Glucose Cotransporter 2 Inhibitors on Nonglycemic Outcomes in Patients with Type 2 Diabetes. Pharmacotherapy. 2017 Apr; 37(4):481-491. PMID: 28102030.
      View in: PubMed
    22. Trujillo JM, McNair CD, Linnebur SA, Valdez C, Trujillo TC. The Impact of a Standalone, Patient-centered Communication Course Series on Student Achievement, Preparedness, and Attitudes. Am J Pharm Educ. 2016 Dec 25; 80(10):174. PMID: 28179723.
      View in: PubMed
    23. Haines ST, Gleason BL, Kantorovich A, McCollum M, Pittenger AL, Plaza CM, Stolte SK, Trujillo JM. Report of the 2015-2016 Academic Affairs Standing Committee. Am J Pharm Educ. 2016 Nov 25; 80(9):S20. PMID: 28090115.
      View in: PubMed
    24. Trujillo JM, Wettergreen SA, Nuffer WA, Ellis SL, McDermott MT. Cardiovascular Outcomes of New Medications for Type 2 Diabetes. Diabetes Technol Ther. 2016 12; 18(12):749-758. PMID: 27835045.
      View in: PubMed
    25. Anderson SL, Trujillo JM. Basal Insulin Use With GLP-1 Receptor Agonists. Diabetes Spectr. 2016 Aug; 29(3):152-60. PMID: 27574369.
      View in: PubMed
    26. Thompson AM, Trujillo JM. Advances in the treatment of type 2 diabetes: impact of dulaglutide. Diabetes Metab Syndr Obes. 2016; 9:125-36. PMID: 27217788.
      View in: PubMed
    27. Nuffer W, Trujillo JM, Megyeri J. A Comparison of New Pharmacological Agents for the Treatment of Obesity. Ann Pharmacother. 2016 May; 50(5):376-88. PMID: 26887340.
      View in: PubMed
    28. Anderson SL, Trujillo JM. Lixisenatide in type 2 diabetes: latest evidence and clinical usefulness. Ther Adv Chronic Dis. 2016 Jan; 7(1):4-17. PMID: 26770666.
      View in: PubMed
    29. Nuffer WA, Trujillo JM. Liraglutide: A New Option for the Treatment of Obesity. Pharmacotherapy. 2015 Oct; 35(10):926-34. PMID: 26497479.
      View in: PubMed
    30. Trujillo JM, Figler TA. Teaching and learning health literacy in a doctor of pharmacy program. Am J Pharm Educ. 2015 Mar 25; 79(2):27. PMID: 25861108.
      View in: PubMed
    31. Hildreth KL, Van Pelt RE, Moreau KL, Grigsby J, Hoth KF, Pelak V, Anderson CA, Parnes B, Kittelson J, Wolfe P, Nakamura T, Linnebur SA, Trujillo JM, Aquilante CL, Schwartz RS. Effects of pioglitazone or exercise in older adults with mild cognitive impairment and insulin resistance: a pilot study. Dement Geriatr Cogn Dis Extra. 2015 Jan-Apr; 5(1):51-63. PMID: 25852732.
      View in: PubMed
    32. Trujillo JM, Nuffer W, Ellis SL. GLP-1 receptor agonists: a review of head-to-head clinical studies. Ther Adv Endocrinol Metab. 2015 Feb; 6(1):19-28. PMID: 25678953.
      View in: PubMed
    33. Thompson AM, Trujillo JM. Dulaglutide: the newest GLP-1 receptor agonist for the management of type 2 diabetes. Ann Pharmacother. 2015 Mar; 49(3):351-9. PMID: 25565404.
      View in: PubMed
    34. Trujillo JM, Nuffer W. GLP-1 receptor agonists for type 2 diabetes mellitus: recent developments and emerging agents. Pharmacotherapy. 2014 Nov; 34(11):1174-86. PMID: 25382096.
      View in: PubMed
    35. Nuffer W, Trujillo JM, Ellis SL. Technosphere insulin (Afrezza): a new, inhaled prandial insulin. Ann Pharmacother. 2015 Jan; 49(1):99-106. PMID: 25313261.
      View in: PubMed
    36. Trujillo JM, Nuffer W. Albiglutide: a new GLP-1 receptor agonist for the treatment of type 2 diabetes. Ann Pharmacother. 2014 Nov; 48(11):1494-501. PMID: 25136065.
      View in: PubMed
    37. Trujillo JM, Saseen JJ, Linnebur SA, Borgelt LM, Hemstreet BA, Fish DN. Impact of student- versus instructor-directed case discussions on student performance in a pharmacotherapy capstone course. Am J Pharm Educ. 2014 Apr 17; 78(3):56. PMID: 24761017.
      View in: PubMed
    38. King WM, McDermott MT, Trujillo JM. Initial management of severe hyperglycemia in patients with type 2 diabetes: an observational study. Diabetes Ther. 2013 Dec; 4(2):375-84. PMID: 23949906.
      View in: PubMed
    39. Hume AL, Kirwin J, Bieber HL, Couchenour RL, Hall DL, Kennedy AK, LaPointe NM, Burkhardt CD, Schilli K, Seaton T, Trujillo J, Wiggins B. Improving care transitions: current practice and future opportunities for pharmacists. Pharmacotherapy. 2012 Nov; 32(11):e326-37. PMID: 23108810.
      View in: PubMed
    40. Anderson SL, Trujillo JM, McDermott M, Saseen JJ. Determining predictors of response to exenatide in type 2 diabetes. J Am Pharm Assoc (2003). 2012 Jul-Aug; 52(4):466-71. PMID: 22825226.
      View in: PubMed
    41. DiVall M, Barr J, Gonyeau M, Matthews SJ, Van Amburgh J, Qualters D, Trujillo J. Follow-up assessment of a faculty peer observation and evaluation program. Am J Pharm Educ. 2012 May 10; 76(4):61. PMID: 22611270.
      View in: PubMed
    42. Anderson SL, Trujillo JM. Association of pancreatitis with glucagon-like peptide-1 agonist use. Ann Pharmacother. 2010 May; 44(5):904-9. PMID: 20371755.
      View in: PubMed
    43. Trujillo J. A drug interactions elective course. Am J Pharm Educ. 2009 Jul 10; 73(4):72. PMID: 19657505.
      View in: PubMed
    44. Trujillo JM, Hardy Y. A Nutrition Journal and Diabetes Shopping Experience to improve pharmacy students' empathy and cultural competence. Am J Pharm Educ. 2009 Apr 07; 73(2):37. PMID: 19513175.
      View in: PubMed
    45. Trujillo JM, DiVall MV, Barr J, Gonyeau M, Van Amburgh JA, Matthews SJ, Qualters D. Development of a peer teaching-assessment program and a peer observation and evaluation tool. Am J Pharm Educ. 2008 Dec 15; 72(6):147. PMID: 19325963.
      View in: PubMed
    46. Trujillo JM, Barsky EE, Greenwood BC, Wahlstrom SA, Shaykevich S, Pendergrass ML, Schnipper JL. Improving glycemic control in medical inpatients: a pilot study. J Hosp Med. 2008 Jan; 3(1):55-63. PMID: 18257047.
      View in: PubMed
    47. Mimbacas A, Trujillo J, Gascue C, Javiel G, Cardoso H. Prevalence of vitamin D receptor gene polymorphism in a Uruguayan population and its relation to type 1 diabetes mellitus. Genet Mol Res. 2007 Sep 05; 6(3):534-42. PMID: 17985306.
      View in: PubMed
    48. Gonyeau MJ, Trujillo J, DiVall M. Development of progressive oral presentations in a therapeutics course series. Am J Pharm Educ. 2006 Apr 15; 70(2):36. PMID: 17139337.
      View in: PubMed
    49. Trujillo JM, Gonyeau MJ, DiVall MV, Alexander SL. Spironolactone use in patients with heart failure. J Clin Pharm Ther. 2004 Apr; 29(2):165-70. PMID: 15068406.
      View in: PubMed
    50. Trujillo JM, Mounts P. Transforming activity of the E6 gene of HPV-11gt in NIH 3T3 and REF 52 cells: correlation with the level of E6 transcription. Virology. 1996 Jun 01; 220(1):1-9. PMID: 8659100.
      View in: PubMed
    51. Escudier SM, Pereira-Leahy JM, Drach JW, Weier HU, Goodacre AM, Cork MA, Trujillo JM, Keating MJ, Andreeff M. Fluorescent in situ hybridization and cytogenetic studies of trisomy 12 in chronic lymphocytic leukemia. Blood. 1993 May 15; 81(10):2702-7. PMID: 7683927.
      View in: PubMed
    52. Chang KS, Fan YH, Stass SA, Estey EH, Wang G, Trujillo JM, Erickson P, Drabkin H. Expression of AML1-ETO fusion transcripts and detection of minimal residual disease in t(8;21)-positive acute myeloid leukemia. Oncogene. 1993 Apr; 8(4):983-8. PMID: 8455949.
      View in: PubMed
    53. Erickson P, Gao J, Chang KS, Look T, Whisenant E, Raimondi S, Lasher R, Trujillo J, Rowley J, Drabkin H. Identification of breakpoints in t(8;21) acute myelogenous leukemia and isolation of a fusion transcript, AML1/ETO, with similarity to Drosophila segmentation gene, runt. Blood. 1992 Oct 01; 80(7):1825-31. PMID: 1391946.
      View in: PubMed
    54. Claxton DF, Reading CL, Nagarajan L, Tsujimoto Y, Andersson BS, Estey E, Cork A, Huh YO, Trujillo J, Deisseroth AB. Correlation of CD2 expression with PML gene breakpoints in patients with acute promyelocytic leukemia. Blood. 1992 Aug 01; 80(3):582-6. PMID: 1353379.
      View in: PubMed
    55. Freireich EJ, Cork A, Stass SA, McCredie KB, Keating MJ, Estey EH, Kantarjian HM, Trujillo JM. Cytogenetics for detection of minimal residual disease in acute myeloblastic leukemia. Leukemia. 1992 Jun; 6(6):500-6. PMID: 1602788.
      View in: PubMed
    56. Lee MS, Kantarjian H, Talpaz M, Freireich EJ, Deisseroth A, Trujillo JM, Stass SA. Detection of minimal residual disease by polymerase chain reaction in Philadelphia chromosome-positive chronic myelogenous leukemia following interferon therapy. Blood. 1992 Apr 15; 79(8):1920-3. PMID: 1562719.
      View in: PubMed
    57. Chang KS, Wang G, Freireich EJ, Daly M, Naylor SL, Trujillo JM, Stass SA. Specific expression of the annexin VIII gene in acute promyelocytic leukemia. Blood. 1992 Apr 01; 79(7):1802-10. PMID: 1313714.
      View in: PubMed
    58. Chang KS, Stass SA, Chu DT, Deaven LL, Trujillo JM, Freireich EJ. Characterization of a fusion cDNA (RARA/myl) transcribed from the t(15;17) translocation breakpoint in acute promyelocytic leukemia. Mol Cell Biol. 1992 Feb; 12(2):800-10. PMID: 1310153.
      View in: PubMed
    59. Chang KS, Lu JF, Wang G, Trujillo JM, Estey E, Cork A, Chu DT, Freireich EJ, Stass SA. The t(15;17) breakpoint in acute promyelocytic leukemia cluster within two different sites of the myl gene: targets for the detection of minimal residual disease by the polymerase chain reaction. Blood. 1992 Feb 01; 79(3):554-8. PMID: 1310060.
      View in: PubMed
    60. Chang KS, Vyas RC, Deaven LL, Trujillo JM, Stass SA, Hittelman WN. PCR amplification of chromosome-specific DNA isolated from flow cytometry-sorted chromosomes. Genomics. 1992 Feb; 12(2):307-12. PMID: 1740340.
      View in: PubMed
    61. Estey E, Trujillo JM, Cork A, O'Brien S, Beran M, Kantarjian H, Keating M, Freireich EJ, Stass S. AML-associated cytogenetic abnormalities (inv (16), del (16), t(8;21)) in patients with myelodysplastic syndromes. Hematol Pathol. 1992; 6(1):43-8. PMID: 1601822.
      View in: PubMed
    62. Jorgenson KF, Antoun GR, Childs CC, Felix EA, Cork A, Yee G, Trujillo JM, Pinkel DP, Zipf TF. 8;20 chromosomal translocation in a case of acute leukemia. Cytogenetic, immunophenotypic, ultrastructural, and molecular characteristics. Cancer Genet Cytogenet. 1991 Mar; 52(1):1-9. PMID: 2009503.
      View in: PubMed
    63. Chang KS, Zhao SR, Wang YP, Lu JF, Trujillo JM, Stass SA, Freireich EJ. Down regulation of myeloperoxidase gene associated with specific nuclease hypersensitive sites during TPA induced differentiation of HL-60. Leukemia. 1991 Mar; 5(3):205-9. PMID: 1849601.
      View in: PubMed
    64. Chang KS, Trujillo JM, Ogura T, Castiglione CM, Kidd KK, Zhao SR, Freireich EJ, Stass SA. Rearrangement of the retinoic acid receptor gene in acute promyelocytic leukemia. Leukemia. 1991 Mar; 5(3):200-4. PMID: 1849600.
      View in: PubMed
    65. Hirsch-Ginsberg C, LeMaistre AC, Kantarjian H, Talpaz M, Cork A, Freireich EJ, Trujillo JM, Lee MS, Stass SA. RAS mutations are rare events in Philadelphia chromosome-negative/bcr gene rearrangement-negative chronic myelogenous leukemia, but are prevalent in chronic myelomonocytic leukemia. Blood. 1990 Sep 15; 76(6):1214-9. PMID: 2205309.
      View in: PubMed
    66. Jiang XY, Trujillo JM, Liang JC. Chromosomal breakpoints within the first intron of the ABL gene are nonrandom in patients with chronic myelogenous leukemia. Blood. 1990 Aug 01; 76(3):597-601. PMID: 2198962.
      View in: PubMed
    67. Chang KS, Trujillo JM, Pugh WC, Freireich EJ, Stass SA. Developmental and differential regulation of human MPO gene in leukemic cells. Leukemia. 1990 Jul; 4(7):497-501. PMID: 2165203.
      View in: PubMed
    68. Claxton D, Kantarjian H, Kurzrock R, Trujillo JM, Gutterman JU, Talpaz M. Alpha interferon dose-dependent suppression of secondary clones in a patient with Philadelphia-positive chronic myelogenous leukemia. Acta Haematol. 1990; 83(3):149-51. PMID: 2109455.
      View in: PubMed
    69. Gagnon GA, Childs CC, LeMaistre A, Keating M, Cork A, Trujillo JM, Nellis K, Freireich E, Stass SA. Molecular heterogeneity in acute leukemia lineage switch. Blood. 1989 Nov 01; 74(6):2088-95. PMID: 2553159.
      View in: PubMed
    70. Jiang XY, Trujillo JM, Dao D, Liang JC. Studies of BCR and ABL gene rearrangements in chronic myelogenous leukemia patients by conventional and pulsed-field gel electrophoresis using gel inserts. Cancer Genet Cytogenet. 1989 Oct 15; 42(2):287-94. PMID: 2676142.
      View in: PubMed
    71. Vadhan-Raj S, Broxmeyer HE, Spitzer G, LeMaistre A, Hultman S, Ventura G, Tigaud JD, Cork MA, Trujillo JM, Gutterman JU, et al. Stimulation of nonclonal hematopoiesis and suppression of the neoplastic clone after treatment with recombinant human granulocyte-macrophage colony-stimulating factor in a patient with therapy-related myelodysplastic syndrome. Blood. 1989 Oct; 74(5):1491-8. PMID: 2676013.
      View in: PubMed
    72. Cason JD, Trujillo JM, Estey EH, Huh YO, Freireich EJ, Stass SA. Peripheral acute leukemia: high peripheral but low-marrow blast count. Blood. 1989 Oct; 74(5):1758-61. PMID: 2790200.
      View in: PubMed
    73. O'Brien S, Kantarjian HM, Keating M, Gagnon G, Cork A, Trujillo J, McCredie KB. Association of granulocytosis with poor prognosis in patients with acute myelogenous leukemia and translocation of chromosomes 8 and 21. J Clin Oncol. 1989 Aug; 7(8):1081-6. PMID: 2754449.
      View in: PubMed
    74. Lee MS, LeMaistre A, Kantarjian HM, Talpaz M, Freireich EJ, Trujillo JM, Stass SA. Detection of two alternative bcr/abl mRNA junctions and minimal residual disease in Philadelphia chromosome positive chronic myelogenous leukemia by polymerase chain reaction. Blood. 1989 Jun; 73(8):2165-70. PMID: 2730954.
      View in: PubMed
    75. LeMaistre A, Lee MS, Talpaz M, Kantarjian HM, Freireich EJ, Deisseroth AB, Trujillo JM, Stass SA. Ras oncogene mutations are rare late stage events in chronic myelogenous leukemia. Blood. 1989 Mar; 73(4):889-91. PMID: 2645949.
      View in: PubMed
    76. Lee MS, Chang KS, Freireich EJ, Kantarjian HM, Talpaz M, Trujillo JM, Stass SA. Detection of minimal residual bcr/abl transcripts by a modified polymerase chain reaction. Blood. 1988 Sep; 72(3):893-7. PMID: 2458151.
      View in: PubMed
    77. Shtalrid M, Talpaz M, Kurzrock R, Kantarjian H, Trujillo J, Gutterman J, Yoffe G, Blick M. Analysis of breakpoints within the bcr gene and their correlation with the clinical course of Philadelphia-positive chronic myelogenous leukemia. Blood. 1988 Aug; 72(2):485-90. PMID: 3165294.
      View in: PubMed
    78. Keating MJ, Smith TL, Kantarjian H, Cork A, Walters R, Trujillo JM, McCredie KB, Gehan EA, Freireich EJ. Cytogenetic pattern in acute myelogenous leukemia: a major reproducible determinant of outcome. Leukemia. 1988 Jul; 2(7):403-12. PMID: 3164797.
      View in: PubMed
    79. Dalton WT, Cork A, Stass SA, Trujillo JM. Chronic myelomonocytic leukemia with trisomy 8 and a related clone with trisomy 8 and t(15;17). Cancer Genet Cytogenet. 1988 Jun; 32(2):287-92. PMID: 3163267.
      View in: PubMed
    80. Liang JC, Chang KS, Schroeder WT, Freireich EJ, Stass SA, Trujillo JM. The myeloperoxidase gene is translocated from chromosome 17 to 15 in a patient with acute promyelocytic leukemia. Cancer Genet Cytogenet. 1988 Jan; 30(1):103-7. PMID: 2825962.
      View in: PubMed
    81. Hirsch-Ginsberg C, Childs C, Chang KS, Beran M, Cork A, Reuben J, Freireich EJ, Chang LC, Bollum FJ, Trujillo J, et al. Phenotypic and molecular heterogeneity in Philadelphia chromosome-positive acute leukemia. Blood. 1988 Jan; 71(1):186-95. PMID: 3334895.
      View in: PubMed
    82. Dalton WT, Ahearn MJ, McCredie KB, Freireich EJ, Stass SA, Trujillo JM. HL-60 cell line was derived from a patient with FAB-M2 and not FAB-M3. Blood. 1988 Jan; 71(1):242-7. PMID: 3422031.
      View in: PubMed
    83. Kurzrock R, Talpaz M, Kantarjian H, Walters R, Saks S, Trujillo JM, Gutterman JU. Therapy of chronic myelogenous leukemia with recombinant interferon-gamma. Blood. 1987 Oct; 70(4):943-7. PMID: 3115339.
      View in: PubMed
    84. Lee MS, Chang KS, Cabanillas F, Freireich EJ, Trujillo JM, Stass SA. Detection of minimal residual cells carrying the t(14;18) by DNA sequence amplification. Science. 1987 Jul 10; 237(4811):175-8. PMID: 3110950.
      View in: PubMed
    85. Lee MS, Blick MB, Pathak S, Trujillo JM, Butler JJ, Katz RL, McLaughlin P, Hagemeister FB, Velasquez WS, Goodacre A, et al. The gene located at chromosome 18 band q21 is rearranged in uncultured diffuse lymphomas as well as follicular lymphomas. Blood. 1987 Jul; 70(1):90-5. PMID: 3297209.
      View in: PubMed
    86. Chang KS, Schroeder W, Siciliano MJ, Thompson LH, McCredie K, Beran M, Freireich EJ, Liang JC, Trujillo JM, Stass SA. The localization of the human myeloperoxidase gene is in close proximity to the translocation breakpoint in acute promyelocytic leukemia. Leukemia. 1987 May; 1(5):458-62. PMID: 2823022.
      View in: PubMed
    87. Lee MS, Chang KS, Trujillo JM, McCredie KB, Keating MJ, Freireich EJ, Stass SA. T-cell receptor gamma chain gene rearrangement in acute myelogenous leukemia--evidence for lymphoid lineage prematurity. Hematol Pathol. 1987; 1(2):93-8. PMID: 2848796.
      View in: PubMed
    88. Estey EH, Keating MJ, Dixon DO, Trujillo JM, McCredie KB, Freireich EJ. Karyotype is prognostically more important than the FAB system's distinction between myelodysplastic syndrome and acute myelogenous leukemia. Hematol Pathol. 1987; 1(4):203-8. PMID: 3504436.
      View in: PubMed
    89. Chang KS, Trujillo JM, Cook RG, Stass SA. Human myeloperoxidase gene: molecular cloning and expression in leukemic cells. Blood. 1986 Dec; 68(6):1411-4. PMID: 3022847.
      View in: PubMed
    90. Holmes RI, Keating MJ, Cork A, Trujillo JM, McCredie KB, Freireich EJ. Loss of the Y chromosome in acute myelogenous leukemia: a report of 13 patients. Cancer Genet Cytogenet. 1985 Jul; 17(3):269-78. PMID: 3859363.
      View in: PubMed
    91. Trujillo JM, Cork A, Ahearn MJ, Youness EL, McCredie KB. Hematologic and cytologic characterization of 8/21 translocation acute granulocytic leukemia. Blood. 1979 Apr; 53(4):695-706. PMID: 284782.
      View in: PubMed
    92. Trujillo JM, Cork A, Drewinko B, Hart JS, Freireich EJ. Case report: tetraploid leukemia. Blood. 1971 Nov; 38(5):632-7. PMID: 5285869.
      View in: PubMed
    Trujillo's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    See all (368) concept(s)
    _
    Co-Authors Expand Description
    See all (23) people
    _
    Similar People Expand Description
    See all (60) people
    _
    Same Department Expand Description
    Search Department

    Copyright © 2021 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)